Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Cancer. 2007 Jun 25;111(3):145-53.

Integration of human papillomavirus vaccination, cytology, and human papillomavirus testing.

Author information

  • Human Papillomavirus Research Unit, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD 20852, USA. schiffmm@mail.nih.gov

Abstract

There is justifiable excitement about the recent introduction of prophylactic vaccines against human papillomavirus (HPV) types 16 (HPV-16) and HPV-18. Preventing these infections theoretically could avert approximately 70% of cervical cancer cases worldwide. In the U.S., numerous influential advocates are calling for universal vaccination of adolescent females. Given the promise of the vaccines, perhaps it is inevitable that vaccine introduction is proceeding before full consideration of how universal vaccination would affect existing, successful cervical cancer prevention programs. Determining the impact and cost effectiveness of the vaccines unavoidably will require time. Nevertheless, it is worth describing in broad terms for the readers of Cancer Cytopathology how successful, broad HPV vaccination of adolescent girls may affect cytology and HPV testing.

Comment in

PMID:
17487850
[PubMed - indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for John Wiley & Sons, Inc.
    Loading ...
    Write to the Help Desk